1. Home
  2. TNYA

as 08-25-2025 10:37am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.

Founded: 2016 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 189.1M IPO Year: 2021
Target Price: $8.60 AVG Volume (30 days): 4.1M
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.89 EPS Growth: N/A
52 Week Low/High: $0.36 - $4.01 Next Earning Date: 08-06-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

TNYA Daily Stock ML Predictions

Share on Social Networks: